| GTO ID | GTC0930 |
| Trial ID | ChiCTR2100046719 |
| Disease | Lymphoma |
| Altered gene | EBV |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EBV CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical study of safety and preliminary efficacy of EBV CAR T cells in patients with relapsed/refractory EBV positive lympohma |
| Year | 2021 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||